Aquestive Therapeutics leverages its PharmFilm platform to develop Anaphylm, a sublingual epinephrine film, a $1B+ market.

The latest announcement is out from Nasus Pharma Ltd. ( (NSRX) ).

"This collaboration represents a significant milestone for Nasus Pharma and for our NS002 program," said Dan Teleman, Chief Executive Officer of Nasus Pharma. "Through this collaboration, Nasus Pharma ...

New patents extend protection for Anaphylm™ into 2037Anaphylm (dibutepinephrine) Sublingual Film, if approved by the FDA, will be the first and ...

San Diego-based ARS Pharmaceuticals, the biotech company behind the FDA-approved epinephrine nasal spray neffy, has filed an antitrust lawsuit against packaging giant AptarGroup Inc., alleging the ...

Adrenaline delivered with liquid or powder nasal sprays is as effective, and sometimes even better, than injected adrenaline, ...

“My review found that intranasal adrenaline, a needle-free alternative delivered as a liquid or dry powder spray, can be as ...

ARS Pharmaceuticals has filed an antitrust lawsuit against AptarGroup , accusing the drug delivery device manufacturer of ...

Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other ...

Instead of stabbing yourself, or someone else, in the thigh with a needle to deliver a dose of adrenaline to counter ...

Instead of stabbing yourself, or someone else, in the thigh with a needle to deliver a dose of adrenaline to counter ...